BMD Summit: Biopharmaceutical Manufacturing and Development
（生物医药品制造开发学会）

学会概要

依据2个历程，深入探讨利用抛弃式设备等的技术实现有效率性的制造设施、及21世纪型制造业基本概念的卓越制造技术之2个重要主题，是有助于提升制造业务敏捷性及控制工程变动性、无与伦比的学会。

现在已确定的演讲：

• 最近Genzyme公司发生偶发性病毒污染事件及为减少将来发生同样污染事件的风险所实施的对策（暂定）
• 作业卓越（operational excellence）的想法在推进工程改善中的作用
• 库存：是资产或不良资产
  产能规划（capacity planning）、供应链平坦化、设置在污染材料周边的防护设施
• 在生物相似性药品（biosimilar）竞争面的优势
  生物制剂制造的经济面与成本最适化的新策略

此外，2010年11月3日(星期三)下午亦预定有到Lonza Hopkinton公司的参访之旅。

主旨演讲

The Future of Biotech Manufacturing
Rick Pierro
President and CEO
Superior Controls

特色演讲

Adventitious Agent Detection and Prevention
Nathan Jones, Ph.D.
Senior Scientist, Purification Process Research
Genzyme Corporation

" This will be a great opportunity to learn what other specialists are doing in the disposables for biotech arena."
- James W. Chrostowski, Ph.D., Engineer III, Biogen Idec

" IBC conferences provide a platform to understand/gauge the best practices of the industry, thus a great opportunity to benchmark oneself! I look forward to being a part of BMD Summit 2010."
- Srinivasan Raman, General Manager, Operations, Biologics Manufacturing, Biocon, India

" Greatly facilitates keeping informed of current key biotech practices, learnings, and players/SMEs."
- Stacey M. Kaneshiro, Senior Consultant Engineer, Eli Lilly and Co.